Skip to results
Modify your search
NARROW
1-11 of 11
Authors: Filip Baert
Sort by
Journal Article
Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases Free
Claire Liefferinckx and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 208–217, https://doi.org/10.1093/ibd/izab042
Published: 30 March 2021
Journal Article
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn’s Disease: A Post Hoc Analysis From the CALM Study Open Access
Walter Reinisch and others
Inflammatory Bowel Diseases, Volume 26, Issue 10, October 2020, Pages 1562–1571, https://doi.org/10.1093/ibd/izaa025
Published: 27 February 2020
Journal Article
Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort
Get access
Peter Bossuyt and others
Inflammatory Bowel Diseases, Volume 25, Issue 1, January 2019, Pages 156–162, https://doi.org/10.1093/ibd/izy219
Published: 15 June 2018
Journal Article
Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study
Get access
Saartje Van de Vondel and others
Inflammatory Bowel Diseases, Volume 24, Issue 5, May 2018, Pages 1099–1105, https://doi.org/10.1093/ibd/izx103
Published: 13 April 2018
Journal Article
Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO)
Get access
Lucas Wauters and others
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1584–1591, https://doi.org/10.1097/MIB.0000000000001193
Published: 10 July 2017
Journal Article
Fecal Calprotectin is a Surrogate Marker for Endoscopic Lesions in Inflammatory Bowel Disease
Get access
Geert D'Haens and others
Inflammatory Bowel Diseases, Volume 18, Issue 12, 1 December 2012, Pages 2218–2224, https://doi.org/10.1002/ibd.22917
Published: 16 February 2012
Journal Article
Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: A Belgian case series
Get access
Marc Ferrante and others
Inflammatory Bowel Diseases, Volume 16, Issue 2, 1 February 2010, Pages 243–249, https://doi.org/10.1002/ibd.21037
Published: 27 July 2009
Journal Article
Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection
Get access
Andre Van Gossum and others
Inflammatory Bowel Diseases, Volume 13, Issue 2, 1 February 2007, Pages 135–142, https://doi.org/10.1002/ibd.20063
Published: 19 December 2006
Journal Article
6-Thioguanine: A Naked Bullet? (or How Pharmacogenomics Can Make Old Drugs Brand New)
Get access
Filip Baert and Paul Rutgeerts
Inflammatory Bowel Diseases, Volume 7, Issue 3, 1 August 2001, Pages 190–191, https://doi.org/10.1097/00054725-200108000-00002
Published: 01 August 2001
Journal Article
Methotrexate in Refractory Crohn's Disease
Get access
Lieven Vandeputte and others
Inflammatory Bowel Diseases, Volume 5, Issue 1, 1 February 1999, Pages 11–15, https://doi.org/10.1097/00054725-199902000-00002
Published: 01 February 1999
Journal Article
Length and Type of Recurrent Ileitis After Ileal Resection Correlate with Presurgical Features in Crohn's Disease
Get access
Geert D'Haens and others
Inflammatory Bowel Diseases, Volume 3, Issue 4, 1 November 1997, Pages 249–253, https://doi.org/10.1097/00054725-199712000-00001
Published: 01 November 1997
Advertisement
Advertisement